EUVIMED · CrossrefZeitschrift
Tumour Virus Research
ISSN 2666-6790 · Elsevier BV
Neueste Artikel
Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat
HTLV-1 HBZ inhibits DHX9 to reprogram circRNA biogenesis in ATLL
HPV8-E6 drives coordinated transcriptional and epigenetic reprogramming of keratinocytes
Modeling of ex vivo immune response reveals a central role for CD8+CD25+ cells in Adult T-cell Leukemia survival: a long-term prospective cohort study
IL-33/IL1RL1 (ST2) signalling drives immune suppression in squamous intraepithelial hyperplasia
HPV integration as a triage tool for HPV-positive women in cervical cancer screening
Locus-specific endogenous retroviral transcriptional modulation in viral hepatitis–driven hepatocellular carcinoma
No evidence for restriction of Beta-HPV8 gene expression by epidermodysplasia verruciformis susceptibility genes CIB1, TMC6, or TMC8 in keratinocytes
How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection
HPV16 genome structure analysis in oropharyngeal cancer PDXs identifies tumors with integrated and episomal genomes
A new role for human papillomavirus 16 E2: Mitotic activation of the DNA damage response to promote viral genome segregation
Human papillomavirus genomics: Understanding carcinogenicity
Synergistic targeting of the PI3K/mTOR and MAPK/ERK pathways in Merkel cell carcinoma
HPV and head and neck cancers: Towards early diagnosis and prevention
Differences in integration frequencies and APOBEC3 profiles of five high-risk HPV types adheres to phylogeny
Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis
Provider preferences for anal cancer prevention screening: Results of the International Anal Neoplasia Society survey
Oral human papillomavirus prevalence, persistence, and risk-factors in HIV-positive and HIV-negative adults
Cervical cancer therapies: Current challenges and future perspectives
Using protection motivation theory to explain the intention to initiate human papillomavirus vaccination among men who have sex with men in China
Human papillomavirus E6 and E7: What remains?
Welcome to Tumour Virus Research
Harnessing immunity for therapy in human papillomavirus driven cancers
Development and evaluation of an online continuing education course to increase healthcare provider self-efficacy to make strong HPV vaccine recommendations to East African immigrant families
Corrigendum to CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings [Papillomavirus Res. 10 (2020) 100206]
Effective HPV vaccination coverage in Australia by number of doses and two-dose spacing: What if one or two doses are sufficient?
Does the number of doses matter? A qualitative study of HPV vaccination acceptability nested in a dose reduction trial in Tanzania
Epstein-Barr virus: Current questions and challenges
Editorial Board
HPV16 and HPV18 type-specific APOBEC3 and integration profiles in different diagnostic categories of cervical samples
EUVIMED